Tonix Pharmaceuticals Holding Corp (TNXP)

NASDAQ
1.4550
+0.0550(+3.93%)
  • Volume:
    1,380,405
  • Day's Range:
    1.3900 - 1.4615
  • 52 wk Range:
    1.1900 - 24.8896

TNXP Overview

Prev. Close
1.4
Day's Range
1.39-1.4615
Revenue
-
Open
1.4
52 wk Range
1.19-24.8896
EPS
-6.34
Volume
1,380,405
Market Cap
62.44M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
11,022,106
P/E Ratio
-
Beta
1.55
1-Year Change
-93.57%
Shares Outstanding
43,061,066
Next Earnings Date
Nov 11, 2022
What is your sentiment on Tonix Pharma?
or
Vote to see community's results!

Tonix Pharmaceuticals Holding Corp News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Tonix Pharmaceuticals Holding Corp Analysis

Tonix Pharmaceuticals Holding Corp Company Profile

Tonix Pharmaceuticals Holding Corp Company Profile

Employees
73

Tonix Pharmaceuticals Holding Corp. (Tonix) is a clinical-stage biopharmaceutical company. It is focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonixs portfolio is primarily composed of immunology and central nervous system (CNS) and infectious disease product candidates. Its immunology portfolio includes biologics to address organ transplant rejection, autoimmune diseases, and cancer. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Its infectious disease portfolio of product candidates includes vaccines to prevent COVID-19, an antiviral to treat COVID-19, and treatment for long COVID. The infectious disease portfolio also includes a vaccine in development to prevent smallpox and monkeypox. Its product candidates include TNX-1500, TNX-1300, TNX-102 SL, TNX-102 SL, TNX-102 SL,TNX-1900,TNX-601 CR, and TNX-1900.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyNeutralSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell
  • what a piece of trash...
    1
    • Any one has information about it?
      0
      • monkey vaxx.
        0
    • Why the hype... Tnx801 is pre-clinical.
      3
      • Exactly... I will buy at 1.50 again
        0
      • René Rasmussen I think the last hole in the chart was result of accumulated fear, which overshadowed common sense. It would rather make sense to me if it didn't go so low (and I hope so, because I bought it for 2.2: D) ... But who knows :) Good luck anyway
        0
      • 50/50 chance money lost or huge profit... Do not spend money you need.
        0
    • I lost at tnxp tons of money, sold it with loss @ .25 (.15 loss per square), then lost money elsewhere :D, because almost every small company crashed (when big companies were hitting highs, small caps stayed around the same value, when big companies crashed, small caps crashed too- not reflecting underevaluation etc., I will not understand this logic, proly just fear...). But now I am coming back (all in), because it seems to me extremely cheap... I guess, there is real chance, that this price will be all time low. Just on paper - real value is 200M, market cap 40 M, thats 5 times undervalued. If they will finally deliver something, it will be the fastest rocket between shares.
      3
      • What a piece of…
        2
        • U r
          0
      • I see this stock climbing to 0.31 in the next month.
        1
        • Oh yeah? It is 0.09 now.
          0
      • Will it be stable on 0.28
        0
        • Now dropping on 5 min chart
          0
          • Tonix Pharmaceuticals Announces FDA Orphan-drug Designation for Tnx-2900 for the Treatment of Prader-willi Syndrome.
            0
            • It is very spooky, whats going on here. I have not seen such dementia in market for a long time. The company seems to me heavily undervalued... I really wonder, why somebody hasn't bought a big pile of shares...
              0